Datasheet

Bifidobacterium infantis (CAT#: LBGF-0722-GF56)

Bifidobacterium infantis is a commercially available probiotic, isolated from infant feces, and hypothesized to grow on 2'-FL because of subspecies identity.

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

CAT Size Price Quantity  
LBGF-0722-GF56
Product Information
Product Overview Bifidobacterium infantis is a commercially available probiotic, isolated from infant feces, and hypothesized to grow on 2'-FL because of subspecies identity.
Target Bifidobacterium
Genus Bifidobacterium
Application Study and research
Culture Medium BBL
Culture Conditions 37°C; Anaerobic
Risk Group 1
Product Format Freeze-dried
Packaging Ampoule tube
Storage -80°C
Shelf Life 6 years
Target Introduction
Introduction Bifidobacterium is Gram-positive, heterofermentative, anaerobic bacteria with a distinctive bifid; i.e. Y shape after which they are named. They are originally isolated from the faeces of breast-fed infants, members of the genus Bifidobacterium are commonly found in the GI tract of mammals. In humans, Bifidobacterium resides within the GI tract, from birth to old age. Disturbances in the microbiota are linked to an ever-growing number of immune-linked disease states including IBD, atopic allergy, arthritis, and obesity. Therefore, there is a significant interest in treating these diseases through microbial or "probiotic" supplementation of patients, including Bifidobacterium. Data from mouse models and clinical trials indicate that Bifidobacterium may have beneficial effects for treating and preventing immune-linked diseases, including gut-associated and systemic conditions. Bifidobacterium have been commercially exploited as probiotic agents due to their associated health benefits and GRAS.
Alternative Names Bifidobacterium infantis
FAQs Published Data Customer Reviews Related Products
  1. What is the primary function of Bifidobacterium infantis in research?

    Bifidobacterium infantis is primarily utilized for its ability to metabolize human milk oligosaccharides (HMOs), aiding in the study of gut microbiota development and its impact on health. This strain is particularly valuable in understanding the gut-brain axis and its implications for cognitive and structural brain development.

  2. What medium should be used for culturing Bifidobacterium infantis?

    Bifidobacterium infantis should be cultured in an anaerobic medium that supports the growth of bifidobacteria, such as MRS broth supplemented with cysteine hydrochloride. The addition of specific prebiotics like 2'-fucosyllactose (2'-FL) can further enhance its growth.

  3. How long does it take for Bifidobacterium infantis to reach log phase growth?

    Under optimal conditions, Bifidobacterium infantis typically reaches log phase growth within 18-24 hours. Monitoring the growth curve is essential to determine the appropriate time for harvesting cells for downstream applications.

  4. What are the steps involved in preparing Bifidobacterium infantis for in vivo studies?

    To prepare Bifidobacterium infantis for in vivo studies, the culture should be grown to the desired phase, harvested by centrifugation, and resuspended in a suitable carrier (e.g., glycerol or PBS). This preparation can then be administered to the experimental subjects, ensuring accurate dosing and consistency.

  5. How can the viability of Bifidobacterium infantis be assessed before use?

    The viability of Bifidobacterium infantis can be assessed using colony-forming unit (CFU) counts on selective agar plates. Viable counts should be performed immediately before use to ensure the probiotic's effectiveness in experiments​.

Bifidobacterium-infantis-Bi-26-1


Total body weight gain of piglet

The research investigated the impact of formula supplementation with 2'-fucosyllactose (2'-FL) and Bifidobacterium longum subsp.infantis Bi-26 (Bi-26) on piglet growth, organ weights, and intestinal development. Utilizing a 2×2 design, two-day-old piglets were randomized to receive either a control diet or a diet supplemented with 1.0 g/L 2'-FL, with further sub-groups receiving either Bi-26 or no probiotic. Over the study period, body weights and food intake were monitored, with no significant differences in formula intake among groups. The study found that piglets fed with 2'-FL or Bi-26 showed a significant reduction in ileal crypt depth, suggesting a potential for decreased intestinal cell proliferation. However, overall growth and organ development were unaffected by the treatments, indicating that supplementation did not adversely affect the animals. The addition of 2'-FL increased sucrase activity in the ileum, highlighting a possible enhancement in digestive function. These findings suggest that 2'-FL and Bi-26 can support piglet growth and intestinal development without negative impacts, potentially offering benefits for formula-fed infants.

Daniels, V. C., Monaco, M. H., et al. Evaluation of 2'-fucosyllactose and Bifidobacterium longum subspecies infantis on growth, organ weights, and intestinal development of piglets. Nutrients. 2021, 14(1): 199. Distributed under Open Access license CC BY 4.0, without modification.

  • Superior Stability and Potency
    The Bifidobacterium infantis; Bi-26 powder from Creative Biolabs ensures superior stability and potency, crucial for consistent results in our microbiome research.
  • Exceptional Consistency
    In our comparative studies, Creative Biolabs' Bifidobacterium infantis; Bi-26 powder consistently outperforms competitors, providing reliable data in gut microbiota research.
  • Consistent Performance in Cultures
    The consistent performance of this powder in bacterial cultures is remarkable, providing reliable growth and activity in every experiment.
  • Reliable Viability Post-Storage
    Even after prolonged storage, this powder maintains high viability, ensuring that experimental results are not compromised.
  • High Consistency in Applications
    Creative Biolabs' Bifidobacterium infantis; Bi-26 powder consistently performs well across various applications, making it a versatile choice for multiple research projects.

Click the button below to contact us or submit your feedback about this product.


Online Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

Live Biotherapeutic

Contact us

Copyright © 2024 Creative Biolabs. All Rights Reserved.

Inquiry Basket